Theracryf Share Discussion Threads

[clocktower] 05/11/2024 18:05:25

Was that your last 40k then lovewins…̷0;.

Good Luck wherever you re-invest, and it would be hard to find a worse one than this has been.

I note your in good humour, so I take it you’re losses were not to painful.

[lovewinshatelosses] 05/11/2024 16:29:03

The one good thing about this name is that it is protected against the new commie government's tax and spend Budget. One that made the previous lot look like...well Conservatives, in comparison. Even though they were basically socialists themselves.
How is it protected? Because it is not going to make anyone any profits, lol :)
Miracles happen, some people think, so maybe this opinion will turn out wrong. It would take one for this to be so.
Now I am finally fully cleared out of here, you may get your miracle. GLA.

[clocktower] 05/11/2024 13:08:48

Will Stalicla be able to raise a larger Series C round, and can it find new larger investment funds to support them?

[clocktower] 04/11/2024 16:46:06

Well although it is down again today the 200k buy exceed the sells for once.

[thiopia] 04/11/2024 14:03:33

Sad news about the Chair Sue Foden.

R.I.P. let's hope Theracryf BoD can deliver on the project before the Grim Reaper claims us all.

[clocktower] 04/11/2024 11:58:33

Sorry wrong thread

[clocktower] 04/11/2024 11:41:00

Hopefully the new chair will have more confidence in the companies prospects than she did, or for that matter any of the other directors have, as they own so few shares in the company.

In her case it was only 125,000 and the only other director to hold shares is Huw Jones and that is a measly 62,500 even though, as most of us know, he professed he wished he could buy shares when they were almost 10 times higher than the currect level.

[clocktower] 04/11/2024 11:09:56

Sad news for her family and friends: Passing of Dr Sue Foden, Chair

[clocktower] 04/11/2024 07:36:43

Thread closed

[clocktower] 02/11/2024 09:01:46

Thanks xxPro.

[xxproinvestorxx] 01/11/2024 16:52:55

That doesn't happen with ISA's due to their tax protection. What you see instead is people doing a 'bed and ISA' - they sell the shares that are in a taxable account and buy back the shares in an ISA to protect from future taxes. Tax is due on any gains made from the purchase/selling of the shares from the taxable account. Currently the ISA limit is £20,000, so at the beginning of the tax year you see lots of trades around this figure. Usually you want to protect shares that are most likely to see significant rises.

[clocktower] 01/11/2024 16:31:47

Thank you for that information xxPro.

I know a lot of folks sell off losers to reduce taxes on winners in the UK, and often buy them back some 30 days later if they can, if they think there is longer term prospects, towards the end of of the tax year but I have no idea how that operates with the like of ISA's investments, maybe you can enlighten me.

Hopefully you are correct about funds flowing into AIM stocks as a result of the CGT.

Have a good weekend.

[xxproinvestorxx] 01/11/2024 15:46:53

ISA's are tax except and while there was a little speculation around ISA changes for the Autumn budget, I highly doubt they had any impact on investment in Theracryf. No changes to ISA's were announced. I doubt even the CGT rumours had much impact, given the share price is at all time lows.Out of all of the changes that were at the forefront of rumours for the Autumn budget, the inheritance tax relief on shares listed on Aim is the most likely to have lead to any selling. Some shares on Aim have been exempt from inheritance tax entirely, with dedicated funds investing in such shares, and it was rumoured that Labour were going to abolish this entirely.However, while they did make changes, Aim listed shares can still carry a 50% relief in IHT (20% instead of the headline 40%). Thus, the fears have proven to be overblown, and there is a possibility Aim shares will slowly see an inflow of funds as a result. On the whole though, the selling is likely just PI's that have had enough waiting, or need the money.

[clocktower] 01/11/2024 11:58:55

I am not familiar with the UK tax regime but reading about the capital gains tax changes, would I be correct that some ISA investors might have been selling up across the board to ensure they were not going to be hit by the recent budget?

Selling their whole portfolio even if it included duffers like this, which would be responsible in part for the very low share price.

I would appreciate it is someone could enlighten me on the subject.

[clocktower] 31/10/2024 16:40:51

Only one MM left on bid, so expect a drop tomorrow.

[clocktower] 31/10/2024 14:39:44

xxPro. If Stalicla are able to raise, they never managed to get the amount they wanted to last time.

So whose to say they and Hugh are not just stringing us along, like he did when he said he wished he could buy shares when they were over 3p.

[clocktower] 31/10/2024 14:32:52

Check out LinkedIn on



Pages 24 to 26 by the way.

[xxproinvestorxx] 31/10/2024 14:27:54

Once Stalicla complete their series C raise, where they are targeting $60-75m, I have no doubt that we'll receive news on them paying us the money owed and their plans to advance STP2 into Phase 2. After all, STP2 has been validated by them as the primary candidate to treat Phenotype 2 ASD, which has a total addressable market in excess of $2B. Clock - Stalicla don't currently have the funds to buy out Theracryf (maybe after series C raise?), and I highly doubt 1p would be accepted by most shareholders, nor would I expect the bod to put forward such a lowball offer to shareholders.The share price is where it is due to several factors and I completely disagree regarding your comments on the share price being where it is due to Stalicla having no intention of ever paying the money for P1 trial completion. The uncertainty is why we are where we are, combined with the wider aim and small biotech environment.

[dave4545] 31/10/2024 13:56:50

ROQ

Friendless at 3.5p not that long ago now 5.5-6p and on no RNS.

I was thinking of buying at 0.64p then I saw the discounted sale and thought might as well wait for 0.6p offer

But any Pharma/Bio can change it's sentiment and then everybody wants to buy in when it's 50% higher

[clocktower] 31/10/2024 13:54:37

tomboyb - Well hopefully it has not been anymore annoying for him than it has been for many of us. The difference being he would not have been able to trade or completely cut his losses when holding such a large stake on or near the highs, so will be sitting on losses.

I decided I would take a look at my overall position today, on this investment/gamble from day one when I started to invest/trade the stock as EVG, and found that at .50 I would break even but from being very substantially in profit it feels like a massive loss, having given the market back all my profits in this dog, that I could have taken off the table back in 2022. Luckily I used my stop losses at 2.5p while still retaining earlier profits in this but foolishly got back in lower down. Still, I had winners and recovered in between.

Since 2007 I stopped taking large positions in small AIM stocks, as I learnt the hard way like JRK will have done with this and TRLS.

Good Luck if you too continue to hold.

In the unlikely event of good news I would add though, as I would trade it again, to take advantage of any spike. To date the lowest I have purchased these for is .64

[tomboyb] 31/10/2024 11:33:40

Additionally you have to feel for James Robert Kight -

He got TRLS wrong as well -

I hope for his sake there is some significant news in the pipeline for this one -

TRLS looks like a con -

[tomboyb] 31/10/2024 11:25:52

Directors only started showing a little interest in the equity by giving themselves options at 0.25p -

No risk to them if the equity keeps getting diluted -

[clocktower] 31/10/2024 11:14:28

If Stalilca were going to pay up, I don't think the share price would be where it is, as it would be cheaper for them to have bought the company for little over 1p imop, which I guess many would be willing to accept.

The only very slim possibility to save this from liquidation is that another deal is struck for NCE OX-1 which on past record of Hugh and Co seems slim.

Even those that paid 1p in the raise must be feeling they were lead down the drain, as the company has not been able to release any positive news since, or kept shareholders up to date.

[tomboyb] 31/10/2024 11:14:04

No one wants to buy it Clock -

600k below Bid -

[clocktower] 31/10/2024 10:57:17

Heading for new lows it seems as the sell off continues.